CodeMap® 

11/18/2021 2020 Part B Utilization Data Loaded
150 North Wacker Drive
Suite 1870
Chicago, IL 60606
847-381-5465 Phone
847-381-4606 Fax
customerservice@codemap.com
      


User Information

Create New Account

Lost Password

Username:
Password:


Quick Links

LCDs and LCAs
by Contractor

PLA Codes

Laboratory Fee Schedule

2022
2021

Physician Fee Schedule

2022
2021

OPPS Fee Schedule

2022-January
2021-October

ASC Fee Schedule

2022-January
2021-October

APC Codes

2022-January
2021-October

DRG Codes

2022
2021

ASP Drug Pricing Files

January 2022
October 2021


CMS Transmittals



Shipping update: 2022 CodeMap Manuals beginning shipping 1/19. All orders will be shipped by January 31.


CodeMap® Compliance Briefing: October 31, 2019


Editor's Welcome: The following CodeMap® Compliance Briefing will discuss several recent developments that should be of concern to clinical laboratories that specialize in drug testing or toxicology. Although most providers of drug testing try to maintain a culture of compliance and ethics, some unscrupulous players continue to commit fraudulent billing practices and provide illegal kickbacks to referral sources. As a result, the OIG and DOJ continue to target these laboratories. In addition to discussing recent enforcement actions concerning drug testing laboratories, this CodeMap® Briefing will also explore the OIG's latest intentions to examine on a global basis Medicare claims and payments for Part B urine drug testing. As always, please forward any comments, ....

Sorry, the full document you are trying to access requires an active subscription.

Please login to the left.


Click here for publications catalog.

--

CodeMap┬« is a Registered Trademark of Wheaton Partners, LLC.